{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:51:13Z","timestamp":1775019073842,"version":"3.50.1"},"reference-count":33,"publisher":"Informa UK Limited","issue":"15","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.4155\/bio-2019-0095","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T13:40:28Z","timestamp":1567777228000},"page":"1389-1403","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Robust LC\u2013MS\/MS Methods for Analysis of Heparan Sulfate Levels in CSF and Brain for Application in Studies of MPS IIIA"],"prefix":"10.1080","volume":"11","author":[{"given":"\u00c5sa","family":"Makower","sequence":"first","affiliation":[{"name":"Swedish Orphan Biovitrum, Tomtebodav\u00e4gen 23A, 112 76Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Arnel\u00f6f","sequence":"additional","affiliation":[{"name":"Swedish Orphan Biovitrum, Tomtebodav\u00e4gen 23A, 112 76Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommy","family":"Andersson","sequence":"additional","affiliation":[{"name":"Swedish Orphan Biovitrum, Tomtebodav\u00e4gen 23A, 112 76Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per-Olof","family":"Edlund","sequence":"additional","affiliation":[{"name":"Swedish Orphan Biovitrum, Tomtebodav\u00e4gen 23A, 112 76Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Gustavsson","sequence":"additional","affiliation":[{"name":"Swedish Orphan Biovitrum, Tomtebodav\u00e4gen 23A, 112 76Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Janson","sequence":"additional","affiliation":[{"name":"Swedish Orphan Biovitrum, Tomtebodav\u00e4gen 23A, 112 76Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan Svensson","family":"Gelius","sequence":"additional","affiliation":[{"name":"Swedish Orphan Biovitrum, Tomtebodav\u00e4gen 23A, 112 76Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agneta","family":"Tjernberg","sequence":"additional","affiliation":[{"name":"Swedish Orphan Biovitrum, Tomtebodav\u00e4gen 23A, 112 76Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0838-5"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.11.079"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2017.10.007"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.60.070191.002303"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2013.11.015"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2005.09.026"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M809637200"},{"issue":"1","key":"e_1_3_6_10_1","first-page":"79","article-title":"Analytical method for the determination of disaccharides derived from keratin, heparan and dermatan sulfate in human serum and plasma by high-performance liquid chromatography\/turbo ionspray ionization tandem mass spectrometry","volume":"368","author":"Oguma T","year":"2006","unstructured":"Oguma T , TomatsuS, MontanoAM, OkazakiO. Analytical method for the determination of disaccharides derived from keratin, heparan and dermatan sulfate in human serum and plasma by high-performance liquid chromatography\/turbo ionspray ionization tandem mass spectrometry. Anal. Chem.368(1), 79\u201386 (2006).","journal-title":"Anal. Chem."},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac3016054"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac2021079"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac3030448"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2009.09.030"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M804288200"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2011.12.063"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.15.243"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.01.012"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.10.001"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.161141"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/9.12.1389"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/11.1.99"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac052083d"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-7192(03)00018-0"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000141987.69757.DD"},{"key":"e_1_3_6_26_1","doi-asserted-by":"crossref","unstructured":"Gustavsson S OhlinSj\u00f6str\u00f6m E TjernbergAet al. Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA mice. Molecular Genetics and Metabolism Letters (2019) (In press).","DOI":"10.1016\/j.ymgmr.2019.100510"},{"key":"e_1_3_6_27_1","unstructured":"US FDA . Guidance for industry on bioanalytical method validation prepared by the Biopharmaceutics Coordinating Committee in the Center for Drug Evaluation and Research (CDER) in cooperation with the Center for Veterinary Medicine (CVM) at the Food and Drug Administration (2001)."},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj0901004"},{"key":"e_1_3_6_29_1","unstructured":"European Medicines Agency Guideline on bioanalytical method validation (2012). www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.287474"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2340083"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2009.06666.x"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2011.04.004"},{"issue":"117","key":"e_1_3_6_34_1","first-page":"1","article-title":"Recommendations on clinical trial design for treatment of mucopolysaccharidosis","volume":"12","author":"Ghosh A","year":"2017","unstructured":"Ghosh A , ShapiroEG, RustSet al. Recommendations on clinical trial design for treatment of mucopolysaccharidosis. Orphanet J. Rare Dis.12(117), 1\u201315 (2017)","journal-title":"Orphanet J. Rare Dis."},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2015.11.001"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/bio-2019-0095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:11:57Z","timestamp":1715958717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/bio-2019-0095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":33,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.4155\/bio-2019-0095"],"URL":"https:\/\/doi.org\/10.4155\/bio-2019-0095","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}